Broderick Brian C Merck & Co., Inc. Transaction History

Broderick Brian C

$470 Million
Q3 2024

A detailed history of Broderick Brian C transactions in Merck & Co., Inc. stock. As of the latest transaction made, Broderick Brian C holds 22,147 shares of MRK stock, worth $2.25 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

22,147

Previous 22,202 0.25%

Holding current value

$2.25 Million

Previous $2.75 Million 8.48%

% of portfolio

0.54%

Previous 0.61%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$111.15 - $128.97 $6,113 - $7,093	-55 Reduced 0.25%	22,147 $2.52 Million
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $78,365 - $84,163	633 Added 2.93%	22,202 $2.75 Million
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $1.58 Million - $1.84 Million	13,944 Added 182.87%	21,569 $2.85 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $150,270 - $163,530	1,500 Added 24.49%	7,625 $831,000
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $2,715 - $2,959	-25 Reduced 0.41%	6,125 $706,000
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $43,720 - $56,055	500 Added 8.85%	6,150 $682,000
Q1 2022 May 17, 2022	BUY	$73.51 - $82.4 $2,572 - $2,884	35 Added 0.62%	5,650 $463,000
Q4 2021 Feb 08, 2022	SELL	$72.28 - $90.54 $250,667 - $313,992	-3,468 Reduced 38.18%	5,615 $431,000
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $19,138 - $21,047	-267 Reduced 2.86%	9,083 $683,000
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $7,031 - $7,777	-100 Reduced 1.06%	9,350 $727,000
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $75,746 - $89,221	-1,100 Reduced 10.43%	9,450 $729,000
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $5,023 - $5,575	-70 Reduced 0.66%	10,550 $862,000
Q3 2020 Oct 28, 2020	SELL	$73.18 - $82.95 $165,020 - $187,052	-2,255 Reduced 17.51%	10,620 $880,000
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $31,689 - $36,058	-450 Reduced 3.38%	12,875 $996,000
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $11,088 - $15,368	-175 Reduced 1.3%	13,325 $1.03 Million
Q4 2019 Jan 15, 2020	BUY	$77.58 - $87.54 $79,209 - $89,378	1,021 Added 8.18%	13,500 $1.23 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $91,448 - $99,681	-1,202 Reduced 8.79%	12,479 $1.05 Million
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $176,695 - $206,422	-2,530 Reduced 15.61%	13,681 $1.15 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $158,990 - $181,337	-2,285 Reduced 12.35%	16,211 $1.35 Million
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $65,239 - $75,710	-1,000 Reduced 5.13%	18,496 $1.41 Million
Q3 2018 Oct 15, 2018	SELL	$57.69 - $67.84 $63,459 - $74,624	-1,100 Reduced 5.34%	19,496 $1.38 Million
Q2 2018 Jul 30, 2018	SELL	$50.83 - $59.72 $5,083 - $5,972	-100 Reduced 0.48%	20,596 $1.25 Million
Q1 2018 Apr 24, 2018	SELL	$50.96 - $59.23 $20,791 - $24,165	-408 Reduced 1.93%	20,696 $1.13 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $766,040 - $914,737	-14,840 Reduced 41.29%	21,104 $1.19 Million
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $2.11 Million - $2.27 Million	35,944	35,944 $2.3 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Account

Broderick Brian C Merck & Co., Inc. Transaction History